AI Verdict
KNSA has stronger fundamentals based on our AI analysis.
KNSA vs KN Fundamental Comparison
| Metric | KNSA | KN |
|---|---|---|
| Revenue | $677.6M | $593.2M |
| Net Income | $59.0M | $44.2M |
| Net Margin | 8.7% | 7.5% |
| ROE | 10.4% | 5.7% |
| ROA | 7.7% | 4.2% |
| Current Ratio | 3.79x | 2.75x |
| Debt/Equity | 0.00x | 0.15x |
| EPS | $0.75 | $0.50 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KNSA vs KN: Frequently Asked Questions
Is KNSA or KN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KNSA has stronger fundamentals. KNSA is rated HOLD (68% confidence) while KN is rated HOLD (58% confidence). This is not investment advice.
How does KNSA compare to KN fundamentally?
Kiniksa Pharmaceuticals International, plc has ROE of 10.4% vs Knowles Corp's 5.7%. Net margins are 8.7% vs 7.5% respectively.
Which stock pays higher dividends, KNSA or KN?
KNSA has a dividend yield of N/A or no dividend while KN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KNSA or KN for long term?
For long-term investing, consider that KNSA has HOLD rating with 68% confidence, while KN has HOLD rating with 58% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KNSA vs KN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KNSA vs KN, the AI consensus favors KNSA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.